http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021044231-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c80a320443e9a6b4f4d1a6566a2305ff
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6725223d77fc74e8260c5595d1d20e47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4bd98b9e14c61fad282ecd97d3f4599
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59825179c53a4f40059867e14d229ab7
publicationDate 2021-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021044231-A3
titleOfInvention Compounds comprising curcumin and basic amino acids
abstract The present invention relates to: a solid compound formed by curcumin and arginine, which includes molar ratios between 5:1 and 1:5, with improved bioavailability properties, and which contains a solid compound comprising curcumin and arginine; the use thereof in complaints of inflammation, pain, stiffness and reduced range of movement, and in complaints that cause disability owing to the presentation of symptoms of pain, inflammation, stiffness and reduced range of movement, among others; and a pharmaceutical composition comprising curcumin and L-arginine with a synergic effect in the therapeutic activity of the combination of curcumin and L-arginine, wherein the selected ratio allows a synergic effect in the therapeutic activity thereof to be obtained, and wherein the preferred ratio of curcumin to L-arginine is between 5:1 and 1:5.
priorityDate 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015085351-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014031403-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3437638-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID969516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID992

Total number of triples: 27.